Sarcomatoid Carcinoma: Clinical Trials

5 trials for Sarcomatoid Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 terminated, 1 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Unknown 1
Phase 11Terminated 1

Follow Sarcomatoid Carcinoma: new trials by email Literature Review of Sarcomatoid Carcinoma trials Research Report on Sarcomatoid Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
postoperative adjuvant therapy - Sarcomatoid Carcinoma, Liver Cancer
RecruitingWest China Hospital502025-04-052025-04-30
Ivonescimab in the Treatment of Multiple Advanced Tumors
Ivocizumab - Pheochromocytoma/Paraganglioma, Rhabdomyosarcoma
Phase 2RecruitingFudan University4002024-11-202025-08-24
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
Diagnostic Test: Sputum DNA methylation analysis, chest CT or pathological examination - Lung Cancer, Small Cell Lung Cancer
CompletedCreative Biosciences (Guangzhou) Co., Ltd.15642022-02-252025-03-21
Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma
Camrelizumab Combined With Apatinib - PD-1 Immunotherapy, VEGFR-TKI
Phase 2UnknownFudan University452021-11-212022-03-04
Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
ADI-PEG 20 - Pleural Mesothelioma Malignant Advanced, Peritoneal Mesothelioma Malignant Advanced
Phase 1TerminatedPolaris Group852014-04-232020-09-25

Narrower conditions

Carcinoma (5)  ·  Adenocarcinoma (1)  ·  Angiomyolipoma (1)  ·  Bronchitis (1)  ·  Bronchitis, Chronic (1)  ·  Carcinoma, Adenosquamous (1)  ·  Carcinoma, Basal Cell (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Large Cell (1)  ·  Carcinoma, Neuroendocrine (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Squamous Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Carcinosarcoma (1)  ·  Glioma (1)

Broader conditions

Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Neoplasms by Site (4)  ·  Adenocarcinoma (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Liver Diseases (2)  ·  Neoplasms, Complex and Mixed (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neuroectodermal Tumors (2)  ·  Neuroendocrine Tumors (2)  ·  Actinomycetales Infections (1)

Interventions

ADI PEG20 (1)  ·  apatinib (1)

Sponsors

Fudan University (2)  ·  Creative Biosciences (Guangzhou) Co., Ltd. (1)  ·  Polaris Group (1)  ·  West China Hospital (1)

Countries

China (4)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Hongxia Wang, Doctor (1)  ·  Laiyu Liu, PhD (1)  ·  Lei Zheng, PhD (1)  ·  Peter Szlosarek, MD, PhD (1)

Results publications

PMID 30796035, PMID 34382365, PMID 35466524